Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01879826 · ClinicalTrials.gov registry record · NA
Pediatric Laser Acupuncture and Renal Biopsy
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT01879826 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 81 participants.
The verdict
NCT01879826, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of this study is to test if treatment with laser therapy in pediatric patients undergoing renal biopsies will improve patient satisfaction of the overall procedure. In this study, the participant will receive a laser acupuncture treatment targeting either kidney acupoints or targeting "sham" points not associated with the kidney; the participant will not get both. Both treatment sessions are given by a certified medical acupuncturist. The patient will still receive standard pain control protocols with anesthetic medications like lidocaine plus ketamine or fentanyl and versed during the biopsy, along with pain management after the procedure. All medication will be administered without regard for which group the participant has been randomized, as the treatment team will also be blinded. Hypothesis: We will test the hypothesis that treatment with laser acupuncture in patients undergoing renal biopsies will improve patient satisfaction of the overall procedure. Specific Aims: Specific Aim 1: Determine whether the use of laser acupuncture improves patient's overall satisfaction of renal biopsy. Specific Aim 2: Determine whether the use of laser acupuncture decreases the amount of sedative medication given during renal biopsy.
Interventions
- DEVICE Aculaser applied to kidney points
- DEVICE Aculaser applied to sham points
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01879826
The ClinicalTrials.gov registry entry for NCT01879826 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aculaser applied to kidney points is the first listed.
NCT01879826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01879826 about?
NCT01879826 is a clinical study titled "Pediatric Laser Acupuncture and Renal Biopsy". The purpose of this study is to test if treatment with laser therapy in pediatric patients undergoing renal biopsies will improve patient satisfaction of the overall procedure. In this study, the participant will receive a laser acupuncture treatment targeting either kidney acupoints or targeting "s...
What is the current status of trial NCT01879826?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2013-07. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01879826?
The interventions under investigation include: Aculaser applied to kidney points (DEVICE), Aculaser applied to sham points (DEVICE).
Who is sponsoring clinical trial NCT01879826?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.